Related Experiment Video

Updated: Jul 20, 2026

Motor and Hippocampal Dependent Spatial Learning and Reference Memory Assessment in a Transgenic Rat Model of Alzheimer's Disease with Stroke
09:45

Motor and Hippocampal Dependent Spatial Learning and Reference Memory Assessment in a Transgenic Rat Model of Alzheimer's Disease with Stroke

Published on: March 22, 2016

Interventions for heart disease and their effects on Alzheimer's disease

Benjamin Wolozin1, Martin M Bednar

  • 1Department of Pharmacology, Boston University School of Medicine, Boston, MA 02118-2526, USA. bwolozin@bu.edu

Neurological Research
|September 2, 2006
PubMed

Insights

Cardiovascular disease risk factors significantly contribute to both Alzheimer's disease and vascular dementia. Managing these factors may offer protective benefits against dementia development and progression.

Area of Science:

  • Neurology
  • Cardiology
  • Gerontology

Background:

  • Cardiovascular diseases (CVD) and dementia, including Alzheimer's disease (AD) and vascular dementia (VaD), represent significant global health challenges.
  • Emerging evidence suggests a strong link between CVD risk factors and the development of dementia.

Purpose of the Study:

  • To review the contributions of cardiovascular disease to Alzheimer's disease and vascular dementia.
  • To explore shared risk factors and potential therapeutic implications.

Main Methods:

  • A comprehensive review of existing literature was conducted.
  • Studies examining the relationship between cardiovascular health and dementia were synthesized.

Main Results:

  • Midlife hypertension and hypercholesterolemia are significant risk factors for both AD and VaD.
  • Diabetes, obesity, and certain surgical stressors (e.g., coronary artery bypass) are also implicated in dementia risk.
  • Apolipoprotein E is a major AD risk factor, potentially acting through neuronal vulnerability rather than solely via cholesterol.

Conclusions:

  • Shared biological pathways likely exist between CVD and dementia, given the overlap in risk factors.
  • Cardiovascular therapies, such as antihypertensives for VaD and statins for AD, may hold promise for dementia prevention and treatment.
Abstract

Related Concept Videos

Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...